awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33597441-9D080A03-4DF8-4BC0-8403-A95BF66B58BD
Q33597441-9D080A03-4DF8-4BC0-8403-A95BF66B58BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33597441-9D080A03-4DF8-4BC0-8403-A95BF66B58BD
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.
P2860
Q33597441-9D080A03-4DF8-4BC0-8403-A95BF66B58BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33597441-9D080A03-4DF8-4BC0-8403-A95BF66B58BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fde6acb3975931dcc78d6e96a2f4b63ad067aa03
P2860
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy.